Blood Pressure During Rate Control in Patients With Tachycardic Atrial Fibrillation at the Emergency Department

Atrial Fibrillation Clinical Trial

— BPIRCTPTAF  

Official title:

Blood Pressure During Rate Control in Patients With Tachycardic Atrial Fibrillation at the Emergency Department

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04005482
• Other study ID #: MUVienna 1568/2014
• Status: Not yet recruiting
• Start date: September 20, 2019
• Est. completion date: July 20, 2021

Study information

• Verified date: September 2019
• Source: Medical University of Vienna
• Contact: Jan Niederdöckl, Dr.med.univ
• Phone: 0043 40400 19640
• Email: jan.niederdoeckl[@]meduniwien.ac.at
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this study is to analyse blood pressure during rate control therapy in patients with tachycardic atrial fibrillation in a real-world emergency cohort.

Description:

Atrial fibrillation (AF) is the primary clinical problem in 3.3% to 10.0 % emergency department (ED) admissions. Rate control is an integral part of the management of symptomatic tachycardic AF patients.

According to the recent guidelines beta-blockers, digoxin, the calcium channel blockers diltiazem and verapamil, amiodarone or combination therapy should be considered for rate control. Haemodynamic side-effects in particular hypotension may occur. Heart rate and blood pressure behavior in an ED population during rate control therapy in patients with tachycardic atrial fibrillation will be analysed.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 140
• Est. completion date: July 20, 2021
• Est. primary completion date: July 20, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 120 Years

Eligibility

Inclusion Criteria:

• Age > 18 years

• Atrial fibrillation or atrial flutter and heart rate = 110 bpm

• Indication for rate control

• Informed consent

Exclusion Criteria:

• Inclusion criteria not met

Related Conditions & MeSH terms

• Atrial Fibrillation
• Emergencies

Intervention

Other:
• Rate control
Rate control according to the Atrial fibrillation - ESC Guidelines 2016

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Vienna

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mean and maximum blood pressure difference between before (baseline) and during/after medication.		20th July 2019 to 20th July 2021